IGC PHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
IGC PHARMA, INC. (IGC) had Lessee, Operating Lease, Liability, to be Paid, Year One of $9.00 thousand as of 2025-12-31, per its 10-KT filed 2026-03-18.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-18
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $9.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $96.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $132.00K.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $151.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $9.00K 10-KT · filed 2026-03-18 |
| 2025-03-31 | $96.00K 10-K · filed 2025-06-27 |
| 2024-03-31 | $132.00K 10-K · filed 2024-06-24 |
| 2023-03-31 | $151.00K 10-K · filed 2023-07-07 |
| 2022-12-31 | $150.00K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $149.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $149.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $148.00K 10-K · filed 2022-06-23 |
| 2021-12-31 | $148.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $146.00K 10-Q · filed 2021-10-29 |
| 2021-06-30 | $145.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $119.00K 10-K · filed 2021-06-14 |
| 2020-12-31 | $118.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $118.00K 10-Q · filed 2020-11-20 |
| 2020-06-30 | $117.00K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $116.00K 10-K · filed 2020-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |